img

Global Anti-diabetic Medication Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-diabetic Medication Market Research Report 2024

Antidiabetic drugs are medicines developed to stabilise and control blood glucose levels amongst people with diabetes.
According to Mr Accuracy reports’s new survey, global Anti-diabetic Medication market is projected to reach US$ 628.9 million in 2029, increasing from US$ 461 million in 2022, with the CAGR of 4.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-diabetic Medication market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-diabetic Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck Sharp & Dohme
Lilly
Novo Nordisk
Huadong Medicine
Bayer
Oddway International
Luye
Uni-Bio Group
Segment by Type
Oral
Injection
Other

Segment by Application


Prevent and Treatment Diabetes
Obesity Treatment
Cardiovascular Protection
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Anti-diabetic Medication report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-diabetic Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Anti-diabetic Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Prevent and Treatment Diabetes
1.3.3 Obesity Treatment
1.3.4 Cardiovascular Protection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-diabetic Medication Market Perspective (2018-2029)
2.2 Anti-diabetic Medication Growth Trends by Region
2.2.1 Global Anti-diabetic Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti-diabetic Medication Historic Market Size by Region (2018-2024)
2.2.3 Anti-diabetic Medication Forecasted Market Size by Region (2024-2029)
2.3 Anti-diabetic Medication Market Dynamics
2.3.1 Anti-diabetic Medication Industry Trends
2.3.2 Anti-diabetic Medication Market Drivers
2.3.3 Anti-diabetic Medication Market Challenges
2.3.4 Anti-diabetic Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-diabetic Medication Players by Revenue
3.1.1 Global Top Anti-diabetic Medication Players by Revenue (2018-2024)
3.1.2 Global Anti-diabetic Medication Revenue Market Share by Players (2018-2024)
3.2 Global Anti-diabetic Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-diabetic Medication Revenue
3.4 Global Anti-diabetic Medication Market Concentration Ratio
3.4.1 Global Anti-diabetic Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-diabetic Medication Revenue in 2022
3.5 Anti-diabetic Medication Key Players Head office and Area Served
3.6 Key Players Anti-diabetic Medication Product Solution and Service
3.7 Date of Enter into Anti-diabetic Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-diabetic Medication Breakdown Data by Type
4.1 Global Anti-diabetic Medication Historic Market Size by Type (2018-2024)
4.2 Global Anti-diabetic Medication Forecasted Market Size by Type (2024-2029)
5 Anti-diabetic Medication Breakdown Data by Application
5.1 Global Anti-diabetic Medication Historic Market Size by Application (2018-2024)
5.2 Global Anti-diabetic Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anti-diabetic Medication Market Size (2018-2029)
6.2 North America Anti-diabetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anti-diabetic Medication Market Size by Country (2018-2024)
6.4 North America Anti-diabetic Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-diabetic Medication Market Size (2018-2029)
7.2 Europe Anti-diabetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anti-diabetic Medication Market Size by Country (2018-2024)
7.4 Europe Anti-diabetic Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-diabetic Medication Market Size (2018-2029)
8.2 Asia-Pacific Anti-diabetic Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anti-diabetic Medication Market Size by Region (2018-2024)
8.4 Asia-Pacific Anti-diabetic Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-diabetic Medication Market Size (2018-2029)
9.2 Latin America Anti-diabetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anti-diabetic Medication Market Size by Country (2018-2024)
9.4 Latin America Anti-diabetic Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-diabetic Medication Market Size (2018-2029)
10.2 Middle East & Africa Anti-diabetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anti-diabetic Medication Market Size by Country (2018-2024)
10.4 Middle East & Africa Anti-diabetic Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Sharp & Dohme
11.1.1 Merck Sharp & Dohme Company Detail
11.1.2 Merck Sharp & Dohme Business Overview
11.1.3 Merck Sharp & Dohme Anti-diabetic Medication Introduction
11.1.4 Merck Sharp & Dohme Revenue in Anti-diabetic Medication Business (2018-2024)
11.1.5 Merck Sharp & Dohme Recent Development
11.2 Lilly
11.2.1 Lilly Company Detail
11.2.2 Lilly Business Overview
11.2.3 Lilly Anti-diabetic Medication Introduction
11.2.4 Lilly Revenue in Anti-diabetic Medication Business (2018-2024)
11.2.5 Lilly Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Anti-diabetic Medication Introduction
11.3.4 Novo Nordisk Revenue in Anti-diabetic Medication Business (2018-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Huadong Medicine
11.4.1 Huadong Medicine Company Detail
11.4.2 Huadong Medicine Business Overview
11.4.3 Huadong Medicine Anti-diabetic Medication Introduction
11.4.4 Huadong Medicine Revenue in Anti-diabetic Medication Business (2018-2024)
11.4.5 Huadong Medicine Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Anti-diabetic Medication Introduction
11.5.4 Bayer Revenue in Anti-diabetic Medication Business (2018-2024)
11.5.5 Bayer Recent Development
11.6 Oddway International
11.6.1 Oddway International Company Detail
11.6.2 Oddway International Business Overview
11.6.3 Oddway International Anti-diabetic Medication Introduction
11.6.4 Oddway International Revenue in Anti-diabetic Medication Business (2018-2024)
11.6.5 Oddway International Recent Development
11.7 Luye
11.7.1 Luye Company Detail
11.7.2 Luye Business Overview
11.7.3 Luye Anti-diabetic Medication Introduction
11.7.4 Luye Revenue in Anti-diabetic Medication Business (2018-2024)
11.7.5 Luye Recent Development
11.8 Uni-Bio Group
11.8.1 Uni-Bio Group Company Detail
11.8.2 Uni-Bio Group Business Overview
11.8.3 Uni-Bio Group Anti-diabetic Medication Introduction
11.8.4 Uni-Bio Group Revenue in Anti-diabetic Medication Business (2018-2024)
11.8.5 Uni-Bio Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-diabetic Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Anti-diabetic Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Anti-diabetic Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Anti-diabetic Medication Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Anti-diabetic Medication Market Share by Region (2018-2024)
Table 9. Global Anti-diabetic Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Anti-diabetic Medication Market Share by Region (2024-2029)
Table 11. Anti-diabetic Medication Market Trends
Table 12. Anti-diabetic Medication Market Drivers
Table 13. Anti-diabetic Medication Market Challenges
Table 14. Anti-diabetic Medication Market Restraints
Table 15. Global Anti-diabetic Medication Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Anti-diabetic Medication Market Share by Players (2018-2024)
Table 17. Global Top Anti-diabetic Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-diabetic Medication as of 2022)
Table 18. Ranking of Global Top Anti-diabetic Medication Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Anti-diabetic Medication Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-diabetic Medication Product Solution and Service
Table 22. Date of Enter into Anti-diabetic Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-diabetic Medication Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Anti-diabetic Medication Revenue Market Share by Type (2018-2024)
Table 26. Global Anti-diabetic Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Anti-diabetic Medication Revenue Market Share by Type (2024-2029)
Table 28. Global Anti-diabetic Medication Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Anti-diabetic Medication Revenue Market Share by Application (2018-2024)
Table 30. Global Anti-diabetic Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Anti-diabetic Medication Revenue Market Share by Application (2024-2029)
Table 32. North America Anti-diabetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Anti-diabetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Anti-diabetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Anti-diabetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Anti-diabetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Anti-diabetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Anti-diabetic Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Anti-diabetic Medication Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Anti-diabetic Medication Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Anti-diabetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Anti-diabetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Anti-diabetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Anti-diabetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Anti-diabetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Anti-diabetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 47. Merck Sharp & Dohme Company Detail
Table 48. Merck Sharp & Dohme Business Overview
Table 49. Merck Sharp & Dohme Anti-diabetic Medication Product
Table 50. Merck Sharp & Dohme Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 51. Merck Sharp & Dohme Recent Development
Table 52. Lilly Company Detail
Table 53. Lilly Business Overview
Table 54. Lilly Anti-diabetic Medication Product
Table 55. Lilly Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 56. Lilly Recent Development
Table 57. Novo Nordisk Company Detail
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Anti-diabetic Medication Product
Table 60. Novo Nordisk Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Huadong Medicine Company Detail
Table 63. Huadong Medicine Business Overview
Table 64. Huadong Medicine Anti-diabetic Medication Product
Table 65. Huadong Medicine Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 66. Huadong Medicine Recent Development
Table 67. Bayer Company Detail
Table 68. Bayer Business Overview
Table 69. Bayer Anti-diabetic Medication Product
Table 70. Bayer Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Oddway International Company Detail
Table 73. Oddway International Business Overview
Table 74. Oddway International Anti-diabetic Medication Product
Table 75. Oddway International Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 76. Oddway International Recent Development
Table 77. Luye Company Detail
Table 78. Luye Business Overview
Table 79. Luye Anti-diabetic Medication Product
Table 80. Luye Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 81. Luye Recent Development
Table 82. Uni-Bio Group Company Detail
Table 83. Uni-Bio Group Business Overview
Table 84. Uni-Bio Group Anti-diabetic Medication Product
Table 85. Uni-Bio Group Revenue in Anti-diabetic Medication Business (2018-2024) & (US$ Million)
Table 86. Uni-Bio Group Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-diabetic Medication Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Anti-diabetic Medication Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Anti-diabetic Medication Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Anti-diabetic Medication Market Share by Application: 2022 VS 2029
Figure 8. Prevent and Treatment Diabetes Case Studies
Figure 9. Obesity Treatment Case Studies
Figure 10. Cardiovascular Protection Case Studies
Figure 11. Other Case Studies
Figure 12. Anti-diabetic Medication Report Years Considered
Figure 13. Global Anti-diabetic Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Anti-diabetic Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Anti-diabetic Medication Market Share by Region: 2022 VS 2029
Figure 16. Global Anti-diabetic Medication Market Share by Players in 2022
Figure 17. Global Top Anti-diabetic Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-diabetic Medication as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Anti-diabetic Medication Revenue in 2022
Figure 19. North America Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Anti-diabetic Medication Market Share by Country (2018-2029)
Figure 21. United States Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Anti-diabetic Medication Market Share by Country (2018-2029)
Figure 25. Germany Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Anti-diabetic Medication Market Share by Region (2018-2029)
Figure 33. China Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Anti-diabetic Medication Market Share by Country (2018-2029)
Figure 41. Mexico Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Anti-diabetic Medication Market Share by Country (2018-2029)
Figure 45. Turkey Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Anti-diabetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Merck Sharp & Dohme Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 48. Lilly Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 49. Novo Nordisk Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 50. Huadong Medicine Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 51. Bayer Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 52. Oddway International Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 53. Luye Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 54. Uni-Bio Group Revenue Growth Rate in Anti-diabetic Medication Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed